Venclexta (venetoclax)

pCPA File Number: 21561
Negotiation Status:
Under consideration for negotiation
Indication(s):
in combination with azacitidine for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) who are 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
PC0238-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable